339 related articles for article (PubMed ID: 32038614)
1. Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against
Palucci I; Maulucci G; De Maio F; Sali M; Romagnoli A; Petrone L; Fimia GM; Sanguinetti M; Goletti D; De Spirito M; Piacentini M; Delogu G
Front Immunol; 2019; 10():3042. PubMed ID: 32038614
[TBL] [Abstract][Full Text] [Related]
2. Cysteamine/Cystamine Exert Anti-
Palucci I; Salustri A; De Maio F; Pereyra Boza MDC; Paglione F; Sali M; Occhigrossi L; D'Eletto M; Rossin F; Goletti D; Sanguinetti M; Piacentini M; Delogu G
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674717
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection.
Palucci I; Matic I; Falasca L; Minerva M; Maulucci G; De Spirito M; Petruccioli E; Goletti D; Rossin F; Piacentini M; Delogu G
J Intern Med; 2018 Mar; 283(3):303-313. PubMed ID: 29205566
[TBL] [Abstract][Full Text] [Related]
4. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant
Lyu XL; Lin TT; Gao JT; Jia HY; Zhu CZ; Li ZH; Dong J; Sun Q; Shu W; Pan LP; Zhang ZD; Li Q
Front Immunol; 2021; 12():796677. PubMed ID: 35003120
[TBL] [Abstract][Full Text] [Related]
5. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
Lee HJ; Ko HJ; Kim SH; Jung YJ
PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
[TBL] [Abstract][Full Text] [Related]
6. Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy.
Ouyang Q; Zhang K; Lin D; Feng CG; Cai Y; Chen X
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269154
[TBL] [Abstract][Full Text] [Related]
7. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2.
Kim JK; Lee HM; Park KS; Shin DM; Kim TS; Kim YS; Suh HW; Kim SY; Kim IS; Kim JM; Son JW; Sohn KM; Jung SS; Chung C; Han SB; Yang CS; Jo EK
Autophagy; 2017 Feb; 13(2):423-441. PubMed ID: 27764573
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice.
Dutta NK; Bruiners N; Zimmerman MD; Tan S; Dartois V; Gennaro ML; Karakousis PC
J Infect Dis; 2020 Mar; 221(7):1079-1087. PubMed ID: 31605489
[TBL] [Abstract][Full Text] [Related]
9. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.
Hawn TR; Shah JA; Kalman D
Immunol Rev; 2015 Mar; 264(1):344-62. PubMed ID: 25703571
[TBL] [Abstract][Full Text] [Related]
10. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
Kiran D; Podell BK; Chambers M; Basaraba RJ
Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
[TBL] [Abstract][Full Text] [Related]
11. Cystamine and cysteamine as inhibitors of transglutaminase activity
Jeitner TM; Pinto JT; Cooper AJL
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054429
[TBL] [Abstract][Full Text] [Related]
12. Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease.
Palucci I; Delogu G
Chemotherapy; 2018; 63(3):172-180. PubMed ID: 30032143
[TBL] [Abstract][Full Text] [Related]
13. Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism.
Palanski BA; Khosla C
Biochemistry; 2018 Jun; 57(24):3359-3363. PubMed ID: 29570977
[TBL] [Abstract][Full Text] [Related]
14. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
Front Immunol; 2020; 11():36. PubMed ID: 32117228
[TBL] [Abstract][Full Text] [Related]
15. Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of
Gupta PK; Jahagirdar P; Tripathi D; Devarajan PV; Kulkarni S
Front Immunol; 2023; 14():1233630. PubMed ID: 37583694
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Tuberculosis Antimicrobials on the Immunometabolic Profiles of Primary Human Macrophages Stimulated with
Cahill C; Cox DJ; O'Connell F; Basdeo SA; Gogan KM; Ó'Maoldomhnaigh C; O'Sullivan J; Keane J; Phelan JJ
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830070
[TBL] [Abstract][Full Text] [Related]
18. Marine-Fungi-Derived Gliotoxin Promotes Autophagy to Suppress
Fu J; Luo X; Lin M; Xiao Z; Huang L; Wang J; Zhu Y; Liu Y; Tao H
Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132937
[TBL] [Abstract][Full Text] [Related]
19. Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine.
Jeon JH; Lee HJ; Jang GY; Kim CW; Shim DM; Cho SY; Yeo EJ; Park SC; Kim IG
Exp Mol Med; 2004 Dec; 36(6):576-81. PubMed ID: 15675041
[TBL] [Abstract][Full Text] [Related]
20. Revisiting hypoxia therapies for tuberculosis.
Oehlers SH
Clin Sci (Lond); 2019 Jun; 133(12):1271-1280. PubMed ID: 31209098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
